company background image
SOHO

Soho Global Health IDX:SOHO Stock Report

Last Price

Rp6.45k

Market Cap

Rp8.2t

7D

2.4%

1Y

29.8%

Updated

20 May, 2022

Data

Company Financials
SOHO fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance6/6
Financial Health6/6
Dividends2/6

SOHO Stock Overview

PT Soho Global Health Tbk operates as a healthcare company in Indonesia.

Soho Global Health Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Soho Global Health
Historical stock prices
Current Share PriceRp6,450.00
52 Week HighRp8,500.00
52 Week LowRp4,700.00
Beta0
1 Month Change0%
3 Month Change-3.37%
1 Year Change29.78%
3 Year Changen/a
5 Year Changen/a
Change since IPO184.14%

Recent News & Updates

Shareholder Returns

SOHOID PharmaceuticalsID Market
7D2.4%1.7%3.1%
1Y29.8%0.5%18.2%

Return vs Industry: SOHO exceeded the ID Pharmaceuticals industry which returned -0.4% over the past year.

Return vs Market: SOHO exceeded the ID Market which returned 17% over the past year.

Price Volatility

Is SOHO's price volatile compared to industry and market?
SOHO volatility
SOHO Average Weekly Movement3.5%
Pharmaceuticals Industry Average Movement3.7%
Market Average Movement6.2%
10% most volatile stocks in ID Market12.1%
10% least volatile stocks in ID Market3.0%

Stable Share Price: SOHO is less volatile than 75% of ID stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: SOHO's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19462,410Paulino La O' Cooeyhttps://www.sohoglobalhealth.com

PT Soho Global Health Tbk operates as a healthcare company in Indonesia. The company operates through Distribution, Professional Product, Consumer Health, Alliance, and Others segments. The company researches, develops, and markets specialty-focused medicines for use in the therapeutic areas of immunomodulator, respiratory, inflammation, and liver diseases; offers nonprescription brand products to treat and prevent diseases; and provides contract manufacturing services for various dosage forms, as well as distribution and logistics services.

Soho Global Health Fundamentals Summary

How do Soho Global Health's earnings and revenue compare to its market cap?
SOHO fundamental statistics
Market CapRp8.19t
Earnings (TTM)Rp563.63b
Revenue (TTM)Rp7.29t

14.5x

P/E Ratio

1.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SOHO income statement (TTM)
RevenueRp7.29t
Cost of RevenueRp5.72t
Gross ProfitRp1.57t
Other ExpensesRp1.01t
EarningsRp563.63b

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)444.09
Gross Margin21.55%
Net Profit Margin7.73%
Debt/Equity Ratio0%

How did SOHO perform over the long term?

See historical performance and comparison

Dividends

3.1%

Current Dividend Yield

98%

Payout Ratio

Valuation

Is Soho Global Health undervalued compared to its fair value and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


20.3%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: SOHO (IDR6450) is trading below our estimate of fair value (IDR8088.65)

Significantly Below Fair Value: SOHO is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: SOHO is good value based on its PE Ratio (14.5x) compared to the ID Pharmaceuticals industry average (20.7x).

PE vs Market: SOHO is good value based on its PE Ratio (14.5x) compared to the ID market (18.6x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate SOHO's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: SOHO is overvalued based on its PB Ratio (3.5x) compared to the ID Pharmaceuticals industry average (2.5x).


Future Growth

How is Soho Global Health forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


15.7%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Soho Global Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Soho Global Health performed over the past 5 years?

Past Performance Score

6/6

Past Performance Score 6/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


49.3%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: SOHO has high quality earnings.

Growing Profit Margin: SOHO's current net profit margins (7.7%) are higher than last year (2.8%).


Past Earnings Growth Analysis

Earnings Trend: SOHO's earnings have grown significantly by 49.3% per year over the past 5 years.

Accelerating Growth: SOHO's earnings growth over the past year (224.4%) exceeds its 5-year average (49.3% per year).

Earnings vs Industry: SOHO earnings growth over the past year (224.4%) exceeded the Pharmaceuticals industry 11.7%.


Return on Equity

High ROE: SOHO's Return on Equity (24%) is considered high.


Financial Health

How is Soho Global Health's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: SOHO's short term assets (IDR3,827.1B) exceed its short term liabilities (IDR1,995.6B).

Long Term Liabilities: SOHO's short term assets (IDR3,827.1B) exceed its long term liabilities (IDR164.2B).


Debt to Equity History and Analysis

Debt Level: SOHO is debt free.

Reducing Debt: SOHO had no debt 5 years ago.

Debt Coverage: SOHO has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: SOHO has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Soho Global Health current dividend yield, its reliability and sustainability?

Dividend Score

1/6

Dividend Score 1/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


3.05%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: SOHO's dividend (3.05%) is higher than the bottom 25% of dividend payers in the ID market (1.14%).

High Dividend: SOHO's dividend (3.05%) is low compared to the top 25% of dividend payers in the ID market (4.15%).


Stability and Growth of Payments

Stable Dividend: Too early to tell whether SOHO's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if SOHO's dividend payments are increasing as they only just started paying a dividend.


Earnings Payout to Shareholders

Earnings Coverage: With its high payout ratio (97.5%), SOHO's dividend payments are not well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (37.7%), SOHO's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Paulino La O' Cooey

no data

Tenure

Mr. Rogelio Castillo La O' Cooey Jr., also known as Paulino, serves as the President Director and CEO of PT Soho Global Health Tbk. Mr. La O' Cooey served as Country Director of Philippines of Smile Train,...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

PT Soho Global Health Tbk's employee growth, exchange listings and data sources


Key Information

  • Name: PT Soho Global Health Tbk
  • Ticker: SOHO
  • Exchange: IDX
  • Founded: 1946
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: Rp8.186t
  • Shares outstanding: 1.27b
  • Website: https://www.sohoglobalhealth.com

Number of Employees


Location

  • PT Soho Global Health Tbk
  • Jl. Rawa Sumur II Kav. BB No. 3
  • Kawasan Industri Pulogadung
  • Jakarta
  • Jakarta Raya
  • 13930
  • Indonesia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/20 00:00
End of Day Share Price2022/05/20 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.